REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research - bioinformant.com/reprocells-i...
@reprocell.bsky.social

REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research -https://bioinformant.com/reprocells-ipsc-seed-stock-clones/

@reprocell.bsky.social

Discover REPROCELL’s StemRNA™ iPSC Seed Stocks featured in BioInformant:

-Ethical, FDA/EMA/PMDA-aligned donor recruitment

-Footprint-free mRNA reprogramming for safety & efficiency

-Multi-modal QC

-Off-the-shelf lines, including HLA homozygous options

Read the article: hubs.li/Q03vdbRd0

REPROCELL’s Clinical-Grade iPSCs: Advancing Cell Therapy - bioinformant.com/reprocells-c...

REPROCELL’s StemRNA(TM) Clinical iPSCs provide a benchmark for clinical grade iPSCs. They provide a foundation for various #celltherapy programs, ensuring safety, consistency, and regulatory compliance.

REPROCELL Unveils New Master Cell Bank Service for Clinical iPSCs#USA#Beltsville#iPSC#REPROCELL#StemRNA

We’re excited to launch highly purified iPSC-derived exosomes for pre-clinical & advanced research, made at our Japan GMP facility. Derived from StemRNA™ clinical-grade iPSCs, available in liquid & lyophilized forms, ideal for anti-aging & collagen production studies.

Learn more: hubs.li/Q03TbmM50

We're excited to add a 23-year-old, Caucasian male (A⁺ blood type) donor line to our StemRNA™ clinical iPSC portfolio. Multiple iPSC clones from this donor are now ready for testing, the perfect foundation for advancing your cell therapy development.

Explore more: hubs.li/Q03PSDPF0

We're excited to announce that REPROCELL & Histocell have jointly achieved AEMPS GMP certification for the manufacturing of 𝗶𝗣𝗦𝗖 𝗠𝗮𝘀𝘁𝗲𝗿 & 𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗖𝗲𝗹𝗹 𝗕𝗮𝗻𝗸𝘀 using REPROCELL’s 𝗦𝘁𝗲𝗺𝗥𝗡𝗔™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖𝘀, produced at Histocell’s newly certified GMP facility in Spain.

Learn more: hubs.li/Q03PgkGb0

REPROCELL now offers our gene-engineered 𝗵𝘆𝗽𝗼𝗶𝗺𝗺𝘂𝗻𝗲 𝗶𝗣𝗦𝗖𝘀 (𝗕𝟮𝗠 𝗼𝗿 𝗱𝘂𝗮𝗹 𝗕𝟮𝗠 + 𝗖𝗜𝗜𝗧𝗔 𝗸𝗻𝗼𝗰𝗸𝗼𝘂𝘁𝘀) in combination with the unmodified parental StemRNA™ iPSC line—a bundle ideal for robust experimental design.

👉 𝗢𝘂𝗿 𝗶𝗣𝗦𝗖𝘀 𝗮𝗿𝗲 𝗯𝘂𝗶𝗹𝘁 𝗳𝗼𝗿 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲.

🌐 hubs.li/Q03GqzMM0

GMP MCB Workflow — Part 2

Who? Our GMP stem cell team in Beltsville uses a closed system to produce iPSCs/iMSCs MCBs.
What? We collect ethically consented skin biopsies, use footprint-free StemRNA™ technology, and expand to GMP MCBs.
Why? Quality, speed, and scale for GMP MCBs.

A New Bundle: StemEdit™ Hypoimmune iPSCs (HLA-Class I or I+II knockouts) plus unmodified matched StemRNA™ parental line (research/clinical-grade version).

Visit: hubs.li/Q03D70k10
Contact: 𝗶𝗻𝗳𝗼-𝘂𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺

What sets our StemRNA™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝗲𝗲𝗱 & 𝗣𝗶𝗹𝗼𝘁 𝗶𝗣𝗦𝗖𝘀 apart?
𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝗲𝗲𝗱 𝗶𝗣𝗦𝗖𝘀: Clinical-grade iPSCs, ready for full-scale-up to GMP MCBs.
𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗶𝗹𝗼𝘁 𝗶𝗣𝗦𝗖: iPSCs expanded from GMP-like Clinical Seed Clones, ideal for early-stage experimentation and method validation.
Learn more: hubs.li/Q03C4mYz0

Building a cell therapy from the ground up? Start with the right foundation. REPROCELL’s 𝗦𝘁𝗲𝗺𝗥𝗡𝗔™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖 𝗦𝗲𝗲𝗱 𝗖𝗹𝗼𝗻𝗲𝘀 are engineered for regulatory success - already included in IND filings & trusted by biopharma leaders worldwide.
Explore our updated webpage: www.reprocell.com/clinical-ste...

Looking for a 𝘀𝗮𝗳𝗲𝗿, 𝗳𝗮𝘀𝘁𝗲𝗿, and 𝗺𝗼𝗿𝗲 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁 way to generate 𝗶𝗣𝗦𝗖𝘀?

Why StemRNA™ 3rd-Generation Reprogramming Kit?

• 𝗙𝗼𝗼𝘁𝗽𝗿𝗶𝗻𝘁-𝗳𝗿𝗲𝗲 iPSC reprogramming
• 𝗛𝗶𝗴𝗵 iPSC formation 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆
• 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲𝗱 𝘁𝗶𝗺𝗲𝗹𝗶𝗻𝗲 & no screening needed

Read the blog: www.reprocell.com/blog/why-mrn...

Could the next breakthrough in 19q12 autism spectrum disorder treatment already be on the shelf? Using patient iPSCs, generated with our StemRNA 3rd Gen Reprogramming Kit, a study revealed hidden potential in an FDA-approved drug.

Link to the paper: www.researchsquare.com/article/rs-6...

Whether you are scaling GMP cell manufacturing or optimizing early-stage research, our StemRNA™ Clinical iPSC Seed & Pilot Clones are designed to meet your specific needs. Explore the table below to identify the best solution for your work.
Contact our experts today: hubs.li/Q03fW5_80

𝗥𝗘𝗣𝗥𝗢𝗖𝗘𝗟𝗟 𝗨𝗦𝗔 at the 2nd Annual Maryland Stem Cell & Regenerative Medicine Showcase. We showcased our GMP iPSC/iMSC advancements, including proprietary StemRNA™ Clinical Reprogramming Technology, with a poster and on-site team. Grateful to the Maryland Stem Cell Research Fund for an inspiring event!